Home»Uncategorized»Multiple Sclerosis

Multiple Sclerosis

0
Shares
Pinterest Google+

Multiple Sclerosis is a demyelinating disease that affects human beings.  The myelin on the nerves is damaged.  This is the insulation of the nerves.  The repair of the nerves or remyelination of the nerves may be a form of treatment of Multiple Sclerosis in the future.    Some symptoms of Multiple Sclerosis may be double-vision or loss of balance.  Tysabri is the most effective  FDA-approved therapy for Multiple Sclerosis to date.  Tysabri prevents the immune cells from getting into the brain across the blood brain barrier.  Alpha-4 integrin is blocked which , in human beings, is necessary for lymphocytes to get into the brain.  This is the most effective FDA-approved Multiple Sclerosis therapy used to date.  Multiple Sclerosis patients fare better if they remain active during the incipient stages of the disease.   Tysabri stops the process of demyelination of neurons of the brain and leads the MS patient down the road to recovery.  Some Multiple Sclerosis patients taking Tysabri improved in function so much that they were able to go back to work.

Plasma exchange therapy is also utilized in the treatment of some patients suffering from  Multiple Sclerosis.  Intravenous lines are used in which the patient is hooked up to a dialysis machine, which then takes the antibodies and other liquid materials out of the blood; and then replaces the blood.  B-interferons are also given to Multiple Sclerosis patients under the skin or in the muscle by injection.  Glutimir may also  be self-injected under the skin.  Novatran, an immune suppressant may be administered every three months; for a limited duration of time only.  Other symptoms of Multiple Sclerosis are fatigue, bladder control trouble, pain, and gait disorder.

Previous post

Puppy with heartbreaking note found abandoned in Vegas airport

Next post

Police, protesters skirmish in Hamburg as G-20 makes city site of global discord

No Comment

Leave a reply

Your email address will not be published. Required fields are marked *